Skip to Content
Merck
  • Protocol to target a promoter region in human embryonic kidney cells using the CRISPR-dCas9 system for single-locus proteomics.

Protocol to target a promoter region in human embryonic kidney cells using the CRISPR-dCas9 system for single-locus proteomics.

STAR protocols (2024-05-01)
Reem Alkhayer, Viviane Ponath, Elke Pogge von Strandmann
ABSTRACT

The unbiased identification of less-abundant transcription factors, which direct the expression of a target gene, is technically challenging. Here, we present a protocol to analyze the locus-specific chromatin-regulating proteome using in situ capture of chromatin interactions by an inactive Cas9 (dCas9). We describe steps for designing guide RNAs and transfection, followed by precipitation of chromatin and associated proteins. In the last step, we describe the elution of DNA and proteins for PCR and mass spectrometric analysis, respectively. For complete details on the use and execution of this protocol, please refer to Alkhayer et al.1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-CRISPR/Cas9 antibody, Mouse monoclonal, clone 7A9-3A3, purified from hybridoma cell culture